Clearmind Medicine Inc. CMND 深 沪
等待开盘 05-12 09:30:00 美东时间
0.5396
-0.023
-4.16%
华盛通- 最 高0.6006
- 今 开0.56
- 成交量 25.32万股
- 最 低 0.5202
- 昨 收 0.563
- 总市值 0
- 52周最高 3.2499
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.0661
- 委 比 -98.58%
- 总股本 --
- 历史最高 6.80
- 量 比 0.63
- 振 幅 14.28%
- 历史最低 0.03
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dow Gains Over 200 Points; US Retail Sales Top Estimates
US stocks up as Dow Jones gains 0.48% and NASDAQ rises 0.03%. Retail sales up 1.7% in March, while private employers add 54,750 jobs per week.
04-21 21:42
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results
US stocks mixed, energy shares climb. Cleveland-Cliffs falls 6% after reporting Q1 results. Enveric Biosciences, Fitness Champs, Clearmind Medicine surge.
04-20 22:08
Market-Moving News for April 20th
MRVL: 7% | Google Teams Up With Marvell Technology To Build New AI Chips, Invests Heavily In TPU Strategy Amid Nvidia Dominance: Report CMND: 110% | Clearmind Medicine Says CMND-100, Proprietary
04-20 19:30
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $17 billion. Shares jump 20.2% to $493.01.
04-20 16:37
Crude Oil Falls Sharply; Wells Fargo Earnings Miss Views
Dow Jones up 200 points, consumer discretionary shares rise 1.8%, Wells Fargo reports worse-than-expected earnings, Avanos Medical surges 69%.
04-15 00:30
Nasdaq Surges 200 Points; Citigroup Posts Upbeat Earnings
US stocks rise, Nasdaq up 200 points. Dow up 0.03%, S&P 500 up 0.35%. Consumer discretionary shares jump 1.4%, energy stocks fall 2.5%. Citigroup beats earnings.
04-14 21:51
Clearmind Medicine's MEAI Included In Bipartisan Legislation In U.S. Congress
The Expanding Veterans' Access to Emerging Treatments Act of 2026 (H.R. 7091) directs the Department of Veterans Affairs (VA) to establish an investigational research and extended access treatment program for innovative
02-03 21:04
Clearmind Medicine Completes Enrollment For Second Cohort Of Phase I/IIa AUD Trial Of CMND-100
Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major
2025-12-16 21:46
Why Did Clearmind Medicine Shares Plunge 29% After Hours?
Clearmind Medicine shares dropped in after-hours trading following the company's announcement of a 1-for-40 reverse stock split.
2025-12-11 16:28
Why Did Clearmind Medicine Shares Jump 7% In Pre-Market Trading?
Clearmind Medicine rose 7.09% in pre-market trading after announcing enrollment of first patient in trial for alcohol use disorder.
2025-11-26 17:32
